Cambridge Cognition Holdings Plc (LON:COG – Get Free Report) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 32.15 and traded as low as GBX 27.10. Cambridge Cognition shares last traded at GBX 27.40, with a volume of 24,906 shares trading hands.
Cambridge Cognition Stock Performance
The business’s fifty day moving average is GBX 31.15 and its 200-day moving average is GBX 32.12. The company has a quick ratio of 0.96, a current ratio of 0.65 and a debt-to-equity ratio of 92.53. The company has a market cap of £12.76 million, a PE ratio of -7.21 and a beta of 0.72.
Cambridge Cognition Company Profile
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.
Further Reading
- Five stocks we like better than Cambridge Cognition
- A month before the crash
- How a Family Trust May Be Able To Help Preserve Your Wealth
- ALERT: Drop these 5 stocks before January 2026!
- Market Panic: Trump Just Dropped a Bomb on Your Stocks
- Trump’s new AI budget just passed — one stock could soar
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.
